The American Hospital Association stated its opposition to a drafted July 28 proposal from the U.S. House Energy and Commerce Committee that could lead to limit access to the 340B Drug Pricing Program in an Aug. 22 letter.
Read the full post on Becker's Hospital Review - Healthcare News
